The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohort.

2.50
Hdl Handle:
http://hdl.handle.net/11287/618266
Title:
The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohort.
Authors:
Chakera, Ali J.; Spyer, G.; Vincent, N.; Ellard, Sian ( 0000-0002-7620-5526 ) ; Hattersley, Andrew T.; Dunne, F. P.
Abstract:
Identifying glucokinase monogenic diabetes (GCK-MODY) in pregnancy is important, as management is different from management for other forms of gestational diabetes mellitus (GDM) and there is no increased maternal risk of type 2 diabetes. We calculated the population prevalence of GCK-MODY in pregnancy and determined the clinical characteristics that differentiate pregnant women with GCK-MODY from those with GDM.
Citation:
The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohort. 2014, 37 (5):1230-6 Diabetes Care
Publisher:
American Diabetes Association
Journal:
Diabetes Care
Issue Date:
Feb-2014
URI:
http://hdl.handle.net/11287/618266
DOI:
10.2337/dc13-2248
PubMed ID:
24550216
Additional Links:
http://care.diabetesjournals.org/cgi/pmidlookup?view=long&pmid=24550216
Type:
Journal Article; Research Support, Non-U.S. Gov't
Language:
en
ISSN:
1935-5548
Appears in Collections:
2014 RD&E publications; Diabetes/Endocrine Services; Molecular Genetics

Full metadata record

DC FieldValue Language
dc.contributor.authorChakera, Ali J.en
dc.contributor.authorSpyer, G.en
dc.contributor.authorVincent, N.en
dc.contributor.authorEllard, Sianen
dc.contributor.authorHattersley, Andrew T.en
dc.contributor.authorDunne, F. P.en
dc.date.accessioned2016-08-11T15:32:15Z-
dc.date.available2016-08-11T15:32:15Z-
dc.date.issued2014-02-
dc.identifier.citationThe 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohort. 2014, 37 (5):1230-6 Diabetes Careen
dc.identifier.issn1935-5548-
dc.identifier.pmid24550216-
dc.identifier.doi10.2337/dc13-2248-
dc.identifier.urihttp://hdl.handle.net/11287/618266-
dc.description.abstractIdentifying glucokinase monogenic diabetes (GCK-MODY) in pregnancy is important, as management is different from management for other forms of gestational diabetes mellitus (GDM) and there is no increased maternal risk of type 2 diabetes. We calculated the population prevalence of GCK-MODY in pregnancy and determined the clinical characteristics that differentiate pregnant women with GCK-MODY from those with GDM.en
dc.language.isoenen
dc.publisherAmerican Diabetes Associationen
dc.relation.urlhttp://care.diabetesjournals.org/cgi/pmidlookup?view=long&pmid=24550216en
dc.rightsArchived with thanks to Diabetes careen
dc.subjectWessex Classification Subject Headings::Endocrinology::Diabetesen
dc.subjectWessex Classification Subject Headings::Obstetrics. Midwiferyen
dc.titleThe 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohort.en
dc.typeJournal Articleen
dc.typeResearch Support, Non-U.S. Gov'ten
dc.identifier.journalDiabetes Careen
dc.type.versionPublisheden

Related articles on PubMed

All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.